Here is the latest news from our programme:
KCE Trials team |
Funding Opportunities
2024 investigator-led call on comparative effectiveness studies The ninth KCE Trials national call for proposals on comparative effectiveness studies is currently open. The deadline for submissions is 13h on 24th September 2024. For full information, including inclusion and exclusion, as well as prioritisation criteria, please visit our website here. 
2024 themed call: Endometriosis care In parallel our first themed call on endometriosis care is currently open. The deadline for submissions is 13h on 24th September 2024. Themed calls invite proposals focusing on a particular research or disease area and can be used to encourage research in an area of particular interest. Full information is available on our website here. 
|
Progress in funded studies
We are happy to announce the following important milestones have been reached in the trials below:
New study
| The contract has been recently signed for the HELIOS study: Proactive therapeutic drug monitoring versus routine care with the novel biologics in psoriasis: a pragmatic, multicentric, randomised, controlled study. The chief investigator is Pr Jo Lambert (UZ Gent). The study will recruit 210 participants in 14 sites. >> read more | |
PULSE | The contract has been recently signed for Belgian participation in the PULSE study: Maintenance Pembrolizumab at Usual or Low doSE in non-squamous lung cancer: a non-inferiority study. Belgian National Coordinator is Prof Aboubakar Nana and the study will be performed in 12 sites in Belgium. >> read more | |
RECOVER@HOME
| Recovery from disability after geriatric-home rehabilitation versus standard of care: a randomised multicentre parallel group pragmatic trial in older patients with disability at hospital discharge. The Chief Investigator is Prof Theo van Achterberg (UZ – KU Leuven) and the pilot will be performed in Leuven and CHU UCL Namur (Mont Godinne). >> read more | |
| SHAPERS First Participant Included | The First Participant has been Included in the SHAPERS study: Efficacy and safety of short-course radiotherapy (SCRT) versus total neoadjuvant therapy in older patients with locally advanced rectal cancer: a multicentre, open-label, randomised pragmatic clinical trial. The Chief Investigator is Prof. Francesco Sclafani (IJB) and the study will be performed in 20 sites. >> read more | |
REPAIR | The First Belgian Participant has been Included in the REPAIR BeNeFIT study 27/03/2024: Targeting suicidality in young adults: a randomized controlled, pragmatic, multicentre trial evaluating the (cost)-effectiveness of Attachment Based Family Therapy compared to Treatment as Usual. National Coordinator is Prof Guy Bosmans (KU Leuven) and the study will be performed in six centres in Belgium. >> read more | |
BE-QUILT | The contract has been recently signed for the BE-Quilt: Comparison of ‘quilting sutures’ with ‘conventional’ sutures and drain placement’ after mastectomy: a multicentre, pragmatic randomised controlled trial. The Chief Investigator is Prof Ann Smeets (UZ Leuven) and the study will be performed in 14 sites. >> read more |
The KCE Trials complete portfolio comprises 55 studies. more info>>
Impact
The latest scientific publications including results are presented below, and links to all publications can be found on the last tab of our dynamic dashboards.
More than 29 000 participants have been recruited so far in KCE funded trials!
Check our dynamic dashboard for real-time recruitment data for all KCE Trials funded studies
